Osler, Hoskin & Harcourt LLP advised Nichi-Iko Pharmaceutical Co. on the sale. Nichi-Iko Pharmaceutical Co., Ltd. sold all issued and outstanding shares of its wholly owned...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised CDPQ on the equity investment in Pomerleau Inc. On December 7, 2022, Caisse de dépôt et Placement du Québec (“CDPQ”)...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP acted for BBH Capital Partners on the matter. BBH Capital Partners entered into an investment agreement with Synex Business Performance Group for...
You must be a Standard 1 Year member to access this content.
